Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy We WroclawiufiledCriticalUniwersytet Przyrodniczy We Wroclawiu
Priority to PL401895ApriorityCriticalpatent/PL217022B1/en
Publication of PL401895A1publicationCriticalpatent/PL401895A1/en
Publication of PL217022B1publicationCriticalpatent/PL217022B1/en
Coloring Foods And Improving Nutritive Qualities
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Wynalazek dotyczy zastosowania preparatu fosfolipidowego z zóltka jaja jako substancji czynnej do wytwarzania leków lub suplementów diety, lub jako skladnik preparatów zlozonych, do stosowania w profilaktyce i leczeniu nadcisnienia tetniczego.The invention relates to the use of a phospholipid preparation from egg yolk as an active substance for the production of drugs or dietary supplements, or as a component of complex preparations for use in the prevention and treatment of hypertension.
PL401895A2012-12-042012-12-04Use of the phospholipid preparation from egg yolk
PL217022B1
(en)
Estra-1,3,5 (10), 16-tetraeno-3-substituted derivatives, pharmaceutical preparations that comprise them and their use in the preparation of medicaments for treating endometriosis.